1 life technologies™ proprietary | aipla winter meeting presentation january 2013
TRANSCRIPT
2Life Technologies™ Proprietary | L i fe Te c h n o l o g i e s To d ay
1000s of products - Research & Applied Markets
• Consumables and instruments used to sequence and analyze DNA
• Consumables and instruments used to analyze gene functions
• Next generation sequencing
• Consumables for all types of sample preparation, gene expression and cellular research
• Cell culture media for drug development• Molecular and cell biology reagents• Endpoint PCR benchtop instruments and consumables
• BioProduction• Forensic Testing• Capillary Eletrophoresis and qPCR instruments• Animal Health and Food Safety• Medical Sciences
Genetic Analysis
Applied Sciences
Research Consumables
3Life Technologies™ Proprietary |
Strong Competitive Advantages In All End Markets
• Broad product offerings• Strong, most scientifically cited brands
• Comprehensive solutions• Customizable e-Procurement offerings• World-renowned media formulation for biotech
• Technology provider to diagnostic laboratories
• Established protocols in Forensics• Growing number of offerings for AgBio,
Food & Safety, Synthetic Genomics
Academic / Government
Pharma /Biotech
CommercialApplications
Hospital / Clinics
4Life Technologies™ Proprietary | 2. Lead product innovati on
Offering a Full Range of Solutions for the Life Science Market
CE Sequencing qPCR Best-in-class reagents and consumables
Confirmation / Validation Sample prep andfollow-on experiments
Next GenerationSequencing
Discovery
5Life Technologies™ Proprietary |
• Launched Pervenio™ lung cancer test service in Q3
• Northern California based genomics testing provider
• CLIA certified lab in all 50 states and physician/patient software infrastructure
Building Our Diagnostics Franchise
• Positions LIFE as a partner of choice for drug and companion diagnostic development
6Life Technologies™ Proprietary |
Life Tech has a Large Patent Porfolio
• Broad and deep patent portfolio
• Over 4,000 owned or controlled patents
• Relevant to molecular diagnostics
• Underlying technologies
• Sample prep
• Genetic analysis
• Methods, reagents and instruments
• Specific molecular Dx assays [developing]
Life Tech’s portfolio relates to underlying molecular Dx technologies